PL2374472T3 - Kompozycje i sposoby leczenia zaburzeń okulistycznych - Google Patents

Kompozycje i sposoby leczenia zaburzeń okulistycznych

Info

Publication number: PL2374472T3
Authority: PL; Poland
Prior art keywords: compositions; methods; ophthalmic disorders; treating ophthalmic; treating
Prior art date: 2006-03-16

Application number

PL11152204T

Other languages

English (en)

Inventor

Pierre Belichard

Original Assignee

Dyax Corp.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-03-16

Filing date

2007-03-13

Publication date

2018-11-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38573251&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2374472(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-03-13 Application filed by Dyax Corp. filed Critical Dyax Corp.

2018-11-30 Publication of PL2374472T3 publication Critical patent/PL2374472T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Ophthalmology & Optometry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

PL11152204T 2006-03-16 2007-03-13 Kompozycje i sposoby leczenia zaburzeń okulistycznych PL2374472T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
EP06360008		2006-03-16
EP06291516		2006-09-26
EP07005182.6A EP1854477B9 (en)	2006-03-16	2007-03-13	Peptides inhibiting plasma kallikrein for use in the treatment of ophthalmic disorders.
EP11152204.1A EP2374472B9 (en)	2006-03-16	2007-03-13	Compositions and methods for treating ophthalmic disorders

Publications (1)

Publication Number	Publication Date
PL2374472T3 true PL2374472T3 (pl)	2018-11-30

Family

ID=38573251

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL11152204T PL2374472T3 (pl)	2006-03-16	2007-03-13	Kompozycje i sposoby leczenia zaburzeń okulistycznych

Country Status (5)

Country	Link
EP (2)	EP1854477B9 (pl)
CY (2)	CY1118767T1 (pl)
DK (1)	DK2374472T3 (pl)
PL (1)	PL2374472T3 (pl)
SI (1)	SI1854477T1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
LT3299377T (lt)	2011-10-07	2021-03-25	Bicyclerd Limited	Struktūrizuoto polipeptido specifiškumo moduliavimas
GB201306623D0 (en) *	2013-04-11	2013-05-29	Bicycle Therapeutics Ltd	Modulation of structured polypeptide specificity

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US38A (en)		1836-10-04		Horizontal boot-clamp
US4079A (en)		1845-06-10		Corn-shei
US4093709A (en)	1975-01-28	1978-06-06	Alza Corporation	Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US4131648A (en)	1975-01-28	1978-12-26	Alza Corporation	Structured orthoester and orthocarbonate drug delivery devices
US4180646A (en)	1975-01-28	1979-12-25	Alza Corporation	Novel orthoester polymers and orthocarbonate polymers
US4079038A (en)	1976-03-05	1978-03-14	Alza Corporation	Poly(carbonates)
JPS6056684B2 (ja)	1977-11-07	1985-12-11	東興薬品工業株式会社	点眼剤
US4271143A (en)	1978-01-25	1981-06-02	Alcon Laboratories, Inc.	Sustained release ophthalmic drug dosage
US4407792A (en)	1979-05-09	1983-10-04	Alcon Laboratories, Inc.	Sustained release ophthalmic drug dosage
US4304767A (en)	1980-05-15	1981-12-08	Sri International	Polymers of di- (and higher functionality) ketene acetals and polyols
US4816567A (en)	1983-04-08	1989-03-28	Genentech, Inc.	Recombinant immunoglobin preparations
WO1985002092A1 (en)	1983-11-14	1985-05-23	Bio-Mimetics Inc.	Bioadhesive compositions and methods of treatment therewith
JPS6147500A (ja)	1984-08-15	1986-03-07	Res Dev Corp Of Japan	キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en)	1984-08-27	1987-11-25	The Board Of Trustees Of The Leland Stanford Junior University	Chimeric receptors by dna splicing and expression
GB8422238D0 (en)	1984-09-03	1984-10-10	Neuberger M S	Chimeric proteins
JPS61134325A (ja)	1984-12-04	1986-06-21	Teijin Ltd	ハイブリツド抗体遺伝子の発現方法
US5187153A (en)	1986-11-17	1993-02-16	Scios Nova Inc.	Methods of treatment using Alzheimer's amyloid polypeptide derivatives
US4946931A (en)	1989-06-14	1990-08-07	Pharmaceutical Delivery Systems, Inc.	Polymers containing carboxy-ortho ester and ortho ester linkages
US5041434A (en)	1991-08-17	1991-08-20	Virginia Lubkin	Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
WO1995021601A2 (en) *	1994-01-11	1995-08-17	Protein Engineering Corporation	Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof
US6057287A (en)	1994-01-11	2000-05-02	Dyax Corp.	Kallikrein-binding "Kunitz domain" proteins and analogues thereof
DK1489097T3 (da)	1994-01-11	2012-01-09	Dyax Corp	Hæmmere af humant plasmin, der er afledt af kunitz-domæner, og nukleinsyrer, der koder for samme
US5786328A (en)	1995-06-05	1998-07-28	Genentech, Inc.	Use of kunitz type plasma kallikrein inhibitors
US6413536B1 (en)	1995-06-07	2002-07-02	Southern Biosystems, Inc.	High viscosity liquid controlled delivery system and medical or surgical device
US5968543A (en)	1996-01-05	1999-10-19	Advanced Polymer Systems, Inc.	Polymers with controlled physical state and bioerodibility
US6087473A (en)	1999-05-26	2000-07-11	Zymogenetics, Inc.	Kunitz domain polypeptide and materials and methods for making it
US6174859B1 (en) *	1999-04-06	2001-01-16	J & D Sciences, Inc.	Method of treatment
WO2001010421A1 (en)	1999-08-06	2001-02-15	Board Of Regents, The University Of Texas System	Drug releasing biodegradable fiber implant
US6613355B2 (en)	2000-05-11	2003-09-02	A.P. Pharma, Inc.	Semi-solid delivery vehicle and pharmaceutical compositions
US6524606B1 (en)	2001-11-16	2003-02-25	Ap Pharma, Inc.	Bioerodible polyorthoesters containing amine groups
US7153829B2 (en)	2002-06-07	2006-12-26	Dyax Corp.	Kallikrein-inhibitor therapies
DK1531791T3 (da)	2002-06-07	2010-11-01	Dyax Corp	Forebyggelse og begrænsning af iskæmi
US6989369B2 (en)	2003-02-07	2006-01-24	Dyax Corp.	Kunitz domain peptides
EP1663281B1 (en)	2003-08-29	2013-12-25	Dyax Corp.	Poly-pegylated protease inhibitors
EP1736465A4 (en)	2004-03-31	2009-06-17	Ajinomoto Kk	ANILINE DERIVATIVES
EP2500031A3 (en)	2005-02-24	2012-12-26	Joslin Diabetes Center, Inc.	Compositions and Methods for Treating Vascular Permeability
WO2008016883A2 (en)	2006-07-31	2008-02-07	Activesite Pharmaceuticals, Inc.	Inhibitors of plasma kallikrein

2007
- 2007-03-13 PL PL11152204T patent/PL2374472T3/pl unknown
- 2007-03-13 DK DK11152204.1T patent/DK2374472T3/en active
- 2007-03-13 EP EP07005182.6A patent/EP1854477B9/en not_active Revoked
- 2007-03-13 SI SI200731849A patent/SI1854477T1/sl unknown
- 2007-03-13 EP EP11152204.1A patent/EP2374472B9/en not_active Revoked
2016
- 2016-11-03 CY CY20161101127T patent/CY1118767T1/el unknown
2018
- 2018-08-01 CY CY181100798T patent/CY1121044T1/el unknown

Also Published As

Publication number	Publication date
EP1854477A2 (en)	2007-11-14
EP1854477A3 (en)	2008-06-11
EP2374472B9 (en)	2019-06-12
SI1854477T1 (sl)	2017-01-31
EP1854477B1 (en)	2016-08-03
DK2374472T3 (en)	2018-08-13
EP2374472A2 (en)	2011-10-12
EP2374472B1 (en)	2018-05-02
EP1854477B9 (en)	2018-03-14
EP2374472A3 (en)	2012-05-16
CY1118767T1 (el)	2017-07-12
CY1121044T1 (el)	2019-12-11

Publication	Publication Date	Title
SI2374472T1 (sl)	2018-11-30	Sestavki in postopki za zdravljenje oftalmoloških motenj
IL291175A (en)	2022-05-01	Compositions and methods for treating collagen-mediated diseases
EP2170309A4 (en)	2010-11-03	METHOD AND COMPOSITIONS FOR THE TREATMENT OF DISEASES
ZA200700918B (en)	2008-10-29	Compositions and methods for treating eye disorders and conditions
EP2083862A4 (en)	2012-09-19	COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES AND DISORDERS
LT2444079T (lt)	2017-03-27	Kompozicijos ir būdai, skirti akių sutrikimų gydymui
EP2083857A4 (en)	2010-03-24	METHOD FOR TREATING INTERFERENCE IN CONNECTION WITH MICA
IL202573A0 (en)	2011-08-01	Methods and compositions for treating allergic diseases
GB2466912B (en)	2012-01-04	Compositions and methods for treating lysosomal disorders
EP1893216A4 (en)	2012-08-08	METHOD AND COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES
IL193936A0 (en)	2009-08-03	Compositions and methods for the treatment of immunoinflammatory disorders
IL198723A0 (en)	2010-02-17	Methods and compositions for therapeutic treatment
HK1149545A1 (en)	2011-10-07	Compositions and methods for treating ophthalmic diseases
IL193697A0 (en)	2009-08-03	Methods for treating cognitive and other disorders
GB0718918D0 (en)	2007-11-07	Compositions and methods for treating skin conditions
PL2056799T3 (pl)	2014-01-31	Kompozycje i sposoby do leczenia lub zapobiegania jaskrze lub jej rozwojowi
HK1129596A1 (en)	2009-12-04	Methods and compositions for treating disease
PL2374472T3 (pl)	2018-11-30	Kompozycje i sposoby leczenia zaburzeń okulistycznych
ZA200807049B (en)	2010-07-28	Compositions and methods for treating collagen-mediated diseases